XML 19 R6.htm IDEA: XBRL DOCUMENT v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
At Market Issuance Sales Agreement
Common Stock
Common Stock
At Market Issuance Sales Agreement
Additional Paid-in Capital
Additional Paid-in Capital
At Market Issuance Sales Agreement
Accumulated Other Comprehensive Income ( Loss)
Accumulated Deficit
Beginning Balance (in shares) at Dec. 31, 2024     116,934,314          
Beginning Balance at Dec. 31, 2024 $ 69,472   $ 12   $ 243,794   $ 0 $ (174,334)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock in connection with the At Market Issuance Sales Agreement, net of issuance cost (in shares)       2,585,646        
Issuance of common stock in connection with the At Market Issuance Sales Agreement, net of issuance cost   $ 8,429       $ 8,429    
Issuance of common stock upon exercise of stock options and vesting of restricted stock units (in shares)     1,026,117          
Issuance of common stock upon exercise of stock options and vesting of restricted stock units 48       48      
Stock-based compensation 1,822       1,822      
Net loss (9,371)             (9,371)
Other comprehensive income (loss) (4)           (4)  
Ending Balance (in shares) at Mar. 31, 2025     120,546,077          
Ending Balance at Mar. 31, 2025 $ 70,396   $ 12   254,093   (4) (183,705)
Beginning Balance (in shares) at Dec. 31, 2025 134,536,592   134,536,592          
Beginning Balance at Dec. 31, 2025 $ 103,815   $ 13   322,156   4 (218,358)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock upon exercise of stock options and vesting of restricted stock units (in shares)     4,557,105          
Issuance of common stock upon exercise of stock options and vesting of restricted stock units 6,686       6,686      
Issuance of common stock upon exchange of stock warrants for shares of common stock (in shares)     190,364          
Issuance of common stock upon exchange of stock warrants for shares of common stock 1,895       1,895      
Stock-based compensation 2,058       2,058      
Net loss (5,046)             (5,046)
Other comprehensive income (loss) $ 6           6  
Ending Balance (in shares) at Mar. 31, 2026 139,284,061   139,284,061          
Ending Balance at Mar. 31, 2026 $ 109,414   $ 13   $ 332,795   $ 10 $ (223,404)